PAVmed outlines strategic milestones for 2025, including Veris implantable device submission
Q4 2024 Management View CEO Lishan Aklog highlighted key strategic changes, including the completed deconsolidation of Lucid Diagnostics and restructuring of convertible debt, enabling PAVmed to ...